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Abstract
Background: The appropriateness of an individual's intra uterine growth is now considered an
important determinant of both short and long term outcomes, yet currently used measures have
several shortcomings. This study demonstrates a method of assessing appropriateness of
intrauterine growth based on the estimation of each individual's optimal newborn dimensions from
routinely available perinatal data. Appropriateness of growth can then be inferred from the ratio
of the value of the observed dimension to that of the optimal dimension.
Methods:  Fractional polynomial regression models including terms for non-pathological
determinants of fetal size (gestational duration, fetal gender and maternal height, age and parity)
were used to predict birth weight, birth length and head circumference from a population without
any major risk factors for sub-optimal intra-uterine growth. This population was selected from a
total population of all singleton, Caucasian births in Western Australia 1998–2002. Births were
excluded if the pregnancy was exposed to factors known to influence fetal growth pathologically.
The values predicted by these models were treated as the optimal values, given infant gender,
gestational age, maternal height, parity, and age.
Results: The selected sample (N = 62,746) comprised 60.5% of the total Caucasian singleton birth
cohort. Equations are presented that predict optimal birth weight, birth length and head
circumference given gestational duration, fetal gender, maternal height, age and parity. The best
fitting models explained 40.5% of variance for birth weight, 32.2% for birth length, and 25.2% for
head circumference at birth.
Conclusion:  Proportion of optimal birth weight (length or head circumference) provides a
method of assessing appropriateness of intrauterine growth that is less dependent on the health of
the reference population or the quality of their morphometric data than is percentile position on
a birth weight distribution.
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Background
Being born small for one's gestational age is associated
with adverse outcomes in both the short and long term [1-
3]. However assessing whether a neonate is at risk of com-
promise on account of inappropriate intrauterine growth
is complicated because not all fetuses should grow at the
same rate [4]. Currently the appropriateness of fetal
growth is usually inferred from the percentile position
that the neonate's birth weight occupies on a gestation-
specific birth weight distribution, that may also be specific
for gender. This practice is unsuitable if the most appro-
priate birth weight for the neonate being assessed is not
the same as that for all members of the population con-
tributing to the distribution. Additional problems associ-
ated with percentile-based standards are (a) the
implications of a given percentile position vary with the
burden of growth restricting pathology in the source pop-
ulation, (b) the estimation of percentile position is impre-
cise at the extremes of a distribution where the
information is of most clinical importance and (c) since
percentile positions represent an ordinal rather than inter-
val or ratio scale, the possibilities for valid statistical
manipulation are limited [5].
This communication seeks to describe, demonstrate and
justify the usefulness of an alternative method of assessing
the appropriateness of fetal growth from information
available in the neonatal record.
This method is based on three underlying concepts:
1. Appropriateness of growth can be expressed as the ratio
of the observed birth dimension to the optimal birth
dimension for that an individual neonate. Considering
the dimension of weight we refer to this ratio as the pro-
portion of optimal birth weight (POBW): a concept simi-
lar to the birth weight ratio [6]. Assessing appropriateness
of growth then requires values for the optimal birth
dimensions for the neonate in question.
2. Optimal intrauterine growth is most likely to be
achieved during pregnancies unaffected by any maternal
or fetal pathology or exposures that can pathologically
affect fetal growth,
3. The many determinants of fetal growth can be classified
as having either a pathological or a non-pathological
effect on growth.
Factors with non-pathological effects on growth include
gestational duration, gender [7-9], maternal size [10] and
parity [7,11] and paternal size [12]. We define optimal
birth weight as that achieved when no factors are present
that can exert a pathological effect on growth. The central
tendency of the distribution of birth weights in a popula-
tion which experiences no factors that exert a pathological
effect on intrauterine growth is taken as the optimal birth
weight for neonates with the same combination of non-
pathological determinants of fetal growth.
Pathological growth determining factors, such as mater-
nal vascular disease or those associated with congenital
malformations, usually restrict fetal growth. More rarely
fetal weight is pathologically increased, the most well
known example being fetal macrosomia induced by
maternal diabetes [13].
It is less useful to categorise as either pathological or non-
pathological those determinants of growth that cannot eas-
ily be altered. Multiple pregnancy and maternal race are
two examples of such determinants.
This paper demonstrates our method of assessing the
appropriateness of fetal growth by deriving equations for
optimal birth weight, birth length and head circumfer-
ence. Gestational duration, fetal gender and maternal
height, age and parity are considered as potential inde-
pendent variables representing the non pathological
determinants of fetal growth. In order to select a popula-
tion with optimal intrauterine growth, all births with evi-
dence of having been exposed to pathological
determinants of fetal growth are excluded. Appropriate-
ness of fetal growth is then expressed as the ratio of the
observed birth dimension to the estimated optimal birth
dimension for a neonate with the same values for non-
pathological determinants of fetal growth. The utility of
this approach is discussed.
Methods
Sample selection
Records of the 126,393 births in Western Australia (WA)
during the period of 1998 to 2002 were obtained from the
Western Australian Maternal and Child Health Research
Database (MCHRDB) [14]. This period was selected
because data concerning whether the mother smoked dur-
ing pregnancy, the most prevalent environmental expo-
sure with a pathological effect on intrauterine growth, are
available on this data base for births from 1998 onwards.
The most recent available cohort at the time of writing was
2002.
Of 1998–2002 WA births, 85% were to Caucasian women
and 96.8% were singletons. This example therefore
derives standards for singletons born to Caucasian
women, see Discussion for generalisability.
To achieve a cohort of Caucasian singletons anticipated to
exhibit optimal fetal growth, any pregnancy with evidence
to suggest that fetal growth may have been affected path-
ologically must be excluded. Stillbirths and deaths beforeBMC Pediatrics 2005, 5:13 http://www.biomedcentral.com/1471-2431/5/13
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28 days were excluded as evidence of a suboptimal intra-
uterine course, which may be associated with abnormal
growth, and, for stillbirths, because duration of intrauter-
ine growth, as opposed to gestational duration to delivery,
is not recorded.
The selection of further exclusion criteria was guided, in
part, by the extensive literature concerning growth restric-
tion as reviewed by Resnik [15]. Suggested exclusion crite-
ria for which data are available in the MCHRDB are listed
in Table 1 in order of their frequency observed in 1998–
2002 WA births. Resnik [15] also suggests that maternal
gestational use of anticonvulsants, cocaine, heroin or
alcohol, maternal thrombophilic disorders and nutri-
tional deprivation are risk factors for growth restriction.
While these variables are not available on the MCHRDB,
0.5% of 1998–2002 WA mothers were recorded as having
epilepsy and may have been on anticonvulsants. The use
of cocaine and heroin are illegal in WA and very likely to
be under-reported in medical records. Their use, along
with that of excess alcohol, is associated with birth defects.
Since both a birth defect and death before 28 days are
exclusion criteria, it is anticipated that the majority of
births significantly affected by these substances will be
excluded. The incidence of thrombophilic disorders varies
with ethnic background and no data are available con-
cerning its frequency in WA pregnant women who are of
mixed ethnic backgrounds. However neither throm-
bophilic disorders nor macro-nutrient deprivation are
noted as problems in the WA pregnant population. Thus
the factors listed in Table 1 are anticipated to represent the
most frequently occurring pathological determinants of
fetal growth in our population and were excluded from
the sample for the purposes of deriving measures of opti-
mal fetal growth. Socio-demographic variables of the
selected sample were compared with those of excluded
Caucasian singletons.
Gestational age data
Since the primary determinant of birth dimensions is the
duration of growth, reliable estimates of gestational dura-
tion (GA) are essential, yet exclusion criteria for poor
quality gestational data are likely to exclude a biased sam-
ple. Details of the algorithm used to obtain the best esti-
mate of GA from all available data are described and
justified elsewhere [16]. Applying this method to the total
1998–2002 WA birth population resulted in no satisfac-
tory gestational estimate being available for only 97 births
(~0.1%) and being beyond the range of 23–42 weeks for
a further 573 subjects. Birth weight and gestational dura-
tion data for remaining births were examined to exclude
combinations so unlikely as to suggest error in the gesta-
tional datum. The cut off birth weights at each gestational
age between 23 and 36 weeks, above which the observa-
tion was excluded, were selected with a view to excluding
infants at least four gestational weeks older than reported,
since break through bleeding at four-week intervals in
early pregnancy is a source of gestational error in women
claiming to be certain of the date of their last menstrual
period. Due to the slower rate of weight accretion with
respect to weight dispersion in infants born at term, this
method of data cleaning is not applicable for births
reported as being at greater than 36 weeks gestational
duration [17].
Analysis
For each of the three response variables (birth weight,
length and head circumference) the Box-Cox transforma-
tion [18] was used to identify the optimal transformation
to reduce non-normality and heteroscedasticity of errors.
Fractional polynomial regression was then used to iden-
tify the best fit transformation of gestational age to
account for any non-linearity in the relationship between
gestational duration and each response variable [19].
Fractional polynomials are a means of identifying the
curve of best fit in cases where non-linearity is possible
but there is no scientific reason to specify the shape of the
non-linear relationship. Royston and Altman claim that
their set of power transformations have the flexibility to
cover almost all likely shapes of non-linear relationship.
The number of possible inflection points is determined by
the order of the fractional polynomials fitted. In this case,
where a sideways "S" shape is expected, 2nd order frac-
tional polynomials, which allow for up to two inflection
points, are sufficient. To aid computation, gestational
duration was included in the fractional polynomial
regressions as GA/100.
Maternal height (cm) and maternal age (years) were
included as linear predictor variables (see Discussion)
centred on the population mean values of 162 cm and 25
years respectively. Infant sex and maternal parity were
included as categorical variables. Parity was categorised
Table 1: Observed frequency of factors known to be associated 
with pathological deviations in fetal growth: All Western 
Australian births 1998–2002.
Factor N %
Maternal Smoking 27,326 21.62
Maternal vascular disease 8,334 6.59
Birth defects [29] 7,520 5.95
Maternal (pre-existing or gestational) diabetes 5,051 4.00
Multiple pregnancy 3,991 3.16
TORCH infectionsa 2,945 2.33
High altitudeb 00 . 0
a) Toxoplasmosis, Rubella, CMV, Herpes
b) No population centre in Western Australia is above 300 m. The 
highest peak (Mt. Meharry) is 1253 m, and like all Western Australian 
peaks, is situated in an unpopulated area.BMC Pediatrics 2005, 5:13 http://www.biomedcentral.com/1471-2431/5/13
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with first birth as the reference, second and third birth as
two separate categories, and fourth and subsequent births
constituting the fourth category. Models were fitted using
SAS (Version 8.2) (SAS Institute Inc., 2001). The fit of
each model was tested by plotting residuals against GA
and against the predicted dependent variable (weight,
length or head circumference at birth). Additionally,
POBWs for 3rd, 10th and 90th percentile birth weight were
estimated within each completed gestational week for
sub-samples of parity and maternal height, to ensure that
the model adjusted appropriately for these non-patholog-
ical determinants. Finally, to aid clinical interpretation of
POBW values, POBW was estimated for the 3rd, 10th and
90th percentile positions by taking the weighted mean of
POBWs estimated for each parity/gender stratum of births
between 38 and 41 gestational weeks inclusive, assuming
a constant maternal height of 162 cm.
Results
Table 2 lists the numbers of births sequentially excluded
by each exclusion criterion, and shows that 62,746 single-
ton Caucasian births remained for analysis. Equations for
optimal growth were derived from this total population
sample of singleton, Caucasian births without recognised
risk factors for growth abnormality, which comprised
49.7% of all Western Australian births and 60.5% of the
Caucasian singleton births. Table 3 compares the distribu-
tions of socio-demographic variables for included births
with those of excluded Caucasian singleton births. As
anticipated, given the sample size and the selection crite-
ria, the difference in all distributions is statistically very
significant, with the exception of gender, which is none-
theless significantly different at the p = .05 level. However
the clinical differences tend to be small with the exception
of the proportion of preterm and very preterm births.
Birth weight
The Box-Cox procedure suggested that square root was the
optimal transformation to use for normalising birth
weight. The optimal fractional polynomial gestational age
terms were GA3 and GA3ln(GA). In multivariate analysis,
maternal age was not a significant predictor of birth
weight. Parameter estimates for the selected best fitting
regression equations for the square root of birth weight
are given in Table 4. This model has an adjusted R2 of
40.5%. The best fitting regression equation for estimating
optimal birth weight (grams) can therefore be expressed
as:
and, of course,
This equation suggests that under our standard conditions
of birth at 40 weeks gestation to a 162 cm primiparous
woman, female infants should weigh 3436.0 g and males
3576.4 g. Second births should weigh 123 g more, third
births 158 g more and fourth or subsequent births 189 g
more than the first birth. An example of the curves
obtained from this equation is shown in Figure 1. The
weighted mean POBWs (across the 8 parity/gender com-
binations) observed at the 3rd, 10th and 90th percentile
positions on the birth weight distribution are shown by
gestational duration across the range 35–42 weeks in Fig-
ure 2. These ratios change little by gestational duration
within this range. The weighted mean POBWs across the
range 38–41 weeks for the 3rd, 10th and 90th percentile
birth weights are 81%, 87% and 115% respectively, Table
7.
Birth length
The Box-Cox procedure suggested that birth length raised
to the power of 0.75 was the optimal transformation to
use for normalising birth length. The optimal fractional
polynomial gestational age terms were GA2 and GA3. In
multivariate analysis, maternal age was not a significant
predictor of birth length. Parameter estimates for the
selected best fitting regression equations for the square
Table 2: Sample selection: the number of births sequentially 
excluded by each exclusion criterion.
Exclusion Criterion Number (%)
excluded
Number
remaining
All WA births 1998–2002 0 126,393
Not Caucasian 18,968 (15.0) 107,425
Multiple pregnancy 3,532 (3.3) 103,893
Stillbirth 606 (0.6) 103,287
Maternal gestational smoking 21,570 (20.9) 81,717
Growth restricting conditionsa 9,970 (12.2) 71,747
Gestation <23 or >42 weeks 146 (0.2) 71,601
Birth weight excessive for GA 75 (0.1) 71,526
Missing essential variableb 5,254 (7.3) 66,272
Death before 28 days 102 (0.2) 66,170
Birth defectc 3,424 (5.2) 62,746
a. as identified in Table 1.
b. Essential variables were maternal height and age, birth weight, 
length and head circumference: almost all exclusions at this stage 
were the result of missing values for maternal height.
c. [28]
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root of birth weight are given in Table 5. This model has
an adjusted R2 of 32.2%. The best fitting regression equa-
tion for estimating optimal birth weight (grams) can
therefore be expressed as:
Table 3: Comparison of distributions of selected characteristics among Caucasian singleton births which were or were not included in 
the study.
Included Excluded*
Denominator, N 62,747 maximum 41,146
Sex p
Male fetus, % (N) 50.62 (31,760) 51.63 (21,242) 0.0014
Gestational age
Mean GA (sd), wks 39.0 (1.6) 38.2 (2.6) <.0001
GA<37 weeks, % (N) 4.55 (2,856) 9.96 (4,099) <.0001
GA<33 weeks, % (N) 0.53 (334) 2.65 (1,092) <.0001
5th-95th percentile, wks 37–41 35–41
Birth weight
Mean weight (sd), g. 3,282 (641) <.0001
5th-95th percentile, g 2695–4270 2265–4170
Birth length
Mean length (sd), cm 50.4 (2.5) 49.5 (3.7) <.0001
5th-95th percentile, cm 46–54 45–54
Birth head circumference
Mean circumference, cm 34.7 (1.6) 34.2 (2.4) <.0001
5th-95th percentile, cm 32–37 31–37
Maternal characteristics
Mean height, cm 165.1 (6.7) 164.7 (6.7) <.0001
5th-95th percentile, cm 154–176 153–176
Mean age, y 29.4 (5.2) 28.5 (5.7) <.0001
5th-95th percentile, y 20–38 19–38
Socio-economic Disadvantage† 1009.3 (78.8) 984.7 (86.0) <.0001
* Variable denominators as a result of missing values.
† [29]
Table 4: Parameter estimates modelling the square root of birth weight (grams)
Independent Variable Parameter 
Estimate
Standard 
Error
t value Pr >|t| 95% confidence limits
Intercept -14.08 0.73 -19.36 <.0001 -15.51 -12.66
GA3 * -1413.6 25.0 -56.43 <.0001 -1463 -1365
GA3 In (GA3) * -2782.5 39.4 -70.55 <.0001 -2860 -2705
Male infant 1.185 0.027 44.22 <.0001 1.13 1.24
Maternal height cm# 0.1077 0.0024 45.63 <.0001 0.103 0.112
2nd birth 1.0277 0.031 33.40 <.0001 0.967 1.088
3rd birth 1.318 0.0399 33.04 <.0001 1.24 1.40
4th and subsequent birth 1.571 0.054 29.33 <.0001 1.46 1.68
GA# × Maternal height 0.00667 0.00123 5.42 <.0001 0.0043 0.0091
Adjusted R2 for this model is 0.405
* indicates non-centred but scaled GA, divided by 100
# indicates a centred variable – GA centred around mean of 40 weeks, maternal height centres around a mean of 162 cmBMC Pediatrics 2005, 5:13 http://www.biomedcentral.com/1471-2431/5/13
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and of course
This equation suggests that under our standard conditions
females should be 50.3 cm long at birth and males should
be 0.83 cm longer. The weighted mean proportions of
optimal crown heel length at 3rd, 10th and 90th percentile
positions of crown heel length were found to be 93%,
95% and 105% respectively, see Table 7.
Birth head circumference
The Box-Cox procedure suggested that it was neither nec-
essary nor desirable to transform head circumference
prior to modelling. The optimal fractional polynomial
gestational age terms were GA and GAln(GA). All
potential predictor variables significantly predicted head
circumference, including maternal age. Parameter esti-
mates for the selected best fitting regression equations for
the square root of birth weight are given in Table 6. This
model has an adjusted R2 of 25.2%. The best fitting regres-
sion equation for estimating optimal birth weight (grams)
can therefore be expressed as:
This equation suggest that under our standard conditions
and for mothers of 25 years, the optimal head circumfer-
ence for females was 34.4 cm and for males, 0.61 cm
Mean of male and female optimal birth weight by gestational  age at delivery and parity, estimated for births to women of  height 162 cm Figure 1
Mean of male and female optimal birth weight by gestational 
age at delivery and parity, estimated for births to women of 
height 162 cm.
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larger. The weighted mean proportions of optimal head
circumference at 3rd, 10th and 90th percentile positions of
head circumference were found to be 93%, 96% and
105% respectively, see Table 7.
Discussion
These regression equations, derived from a population
based sample of more than 62,000 singleton Caucasian
pregnancies without the major risk factors for intrauterine
growth anomaly, demonstrate the method used at our
Institute to assess appropriateness of fetal growth. The
method is applicable to all populations with suitable data
Table 5: Parameter estimates modelling birth crown heel length to the power of 0.75 (cm)
Independent Variable Parameter 
Estimate
Standard Error t value Pr >|t| 95% confidence limits
Intercept 5.684 0.176 32.30 <.0001 5.34 6.03
Scaled gestational age 
squared*
209.9 3.66 57.31 <.0001 203 217
Scaled gestational age 
cubed*
-318.5 6.44 -49.43 <.0001 -331 -305
Male infant 0.2350 0.0047 50.08 <.0001 0.226 0.244
Maternal height c# 0.01665 0.00042 40.28 <.0001 0.0158 0.0174
2nd birth 0.07484 0.0054 13.89 <.0001 0.064 0.085
3rd birth 0.1161 0.0070 16.62 <.0001 0.102 0.130
4th and subsequent birth 0.1508 0.0094 16.09 <.0001 0.132 0.169
GA# × Maternal height 0.000763 0.000215 3.54 0.0004 0.00034 0.00120
Adjusted R2 for this model is 0.322
* indicates non-centred but scaled GA, divided by 100
# indicates a centred variable – GA centred around mean of 40 weeks, maternal height centres around a mean of 162 cm
Table 6: Parameter estimates modelling head circumference at birth (cm)
Independent 
Variable
Parameter 
Estimate
Standard Error t value Pr >|t| 95% confidence limits
Intercept -88.31 1.92 -46.31 <.0001 -92.04 -84.57
Scaled 
gestational age*
43.31 0.38 115.06 <.0001 42.57 44.05
GA ln (GA) * -287.6 5.1 -56.32 <.0001 -297.6 -277.6
Male infant 0.6072 0.0109 55.89 <.0001 0.5860 0.6285
Maternal height 
cm #
0.02745 0.000956 28.68 <.0001 0.0256 0.0293
2nd birth 0.2352 0.0127 18.52 <.0001 0.210 0.260
3rd birth 0.3151 0.0167 18.92 <.0001 0.282 0.348
4th and 
subsequent birth
0.3394 0.0225 15.09 <.0001 0.295 0.384
Maternal age # 0.01322 0.00110 12.01 <.0001 0.0111 0.0154
GA# × Maternal 
height
0.00107 0.000498 2.14 0.0321 0.000091 0.00205
Adjusted R2 for this model is 0.252
* indicates non-centred but scaled GA, divided by 100
# indicates a centred variable – GA centred around mean of 40 weeks, maternal height is centred around a mean of 162 cm, maternal age is centred 
around a mean of 25 years
Table 7: Percentage of optimal birth dimension equivalences of 
percentile cut points from which appropriateness of growth has 
traditionally been inferred: as observed in this sample of 
optimally grown neonates.
Percentage of optimal birth dimension (%)
Percentile Position Weight Length Head circumference
3rd 80 93 93
10th 87 95 96
90th 115 105 105BMC Pediatrics 2005, 5:13 http://www.biomedcentral.com/1471-2431/5/13
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available. Our results may be directly applicable to other
populations besides Western Australian Caucasian and
Aboriginal singletons, and we consider it likely to be
applicable to all Caucasian populations, but applicability
should be verified as suggested below.
Advantages of the ratio method
The use of ratios, such as POBW, in the measurement of
intrauterine growth is not a novel idea, [6,20] but has not
been universally adopted despite the many advantages of
ratios over the more commonly used percentile positions.
The following discussion applies to all ratios of optimal
dimensions, but, for simplicity POBW will be used as the
example throughout. These advantages are:
a) Ratios, such as POBW, represent continuous interval
measures.
b) Estimations of POBW require only a single standard
value, the predicted optimal birth weight, rather than val-
ues at several points on the birth weight distribution. The
precision of estimating a percentile position varies
inversely with observation density and, since the majority
of distributions have fewer observations at the extremes,
extreme observations will be the least precise, whatever
the size of the sample generating the distribution. Extreme
observations are also most subject to error. When verifica-
tion of individual observations is not possible (as with de-
identified data), it is a common practice to exclude
extreme values on the assumption that they are in error,
significantly altering the estimated value of extreme per-
centile positions. The positions of percentile extremes are
therefore both imprecise and sensitive to actual and per-
ceived data quality. The most precise percentile estimates
are those at the highest observation densities, which, since
many distributions are akin to Gaussian (particularly
those of birth dimensions), is often the 50th percentile or
median[5].
c) Births affected by growth disturbing factors are over-
represented in the extremes of the growth distribution.
Hence the positions of extreme percentiles are sensitive to
the incidence of growth affecting pathologies in the refer-
ence population and vary with the health of the reference
population. For example, a newborn with a POBW of
85% might be at the 20th percentile position of the birth
weight distribution for a population with a high burden
of growth restricting pathologies, but the 8th percentile of
a population with optimal fetal growth. For an extreme
percentile position to be meaningful therefore, the health
status of the population from which it is derived needs to
be defined, whereas the predicted birth weight is less sen-
sitive to disease burden. Though less sensitive, the propor-
tion of the reference population with growth disturbing
factors will also affect the predicted birth weight, except in
the unlikely situation where pathological restriction is
balanced by pathological acceleration. For this reason we
sought to identify a population without growth disturbing
factors. The ratio of observed birth weight to predicted
birth weight is more generalisable than extreme percentile
positions, and the ratio of observed to predicted optimal
birth weight is even more generalisable[5].
d) POBW is a continuous scale that correlates with weight
deficit, whereas percentile position is an ordinal scale that
does not. For example, Table 8 considers a population
sample with a normal (Gaussian) birth weight distribu-
tion, mean birth weight of 3,400 g and standard deviation
of 345 g. Being Gaussian, the predicted weight equals the
mean (and 50th percentile position) or 3,400 g. In Table 8,
changes in percentile position of 4 or 5 percentile points
are shown to represent changes in weight of between 43 g
and 151 g depending on the particular percentile
positions, whereas, within a population, there is a linear
correlation between differences in weight and change in
POBW. Equivalent changes in percentile position do not
represent equivalent changes in weight. Furthermore, in a
total population the presence of growth restricting factors
creates a negatively skewed (non-Gaussian) birth weight
distribution, so the observed range of birth weights cov-
ered by extreme percentiles is broader than indicated in
Table 8 and is unpredictable.
Table 8: Comparison of changes in percentile position and in POBW for selected changes in birth weight, for a neonate with an 
estimated optimal birth weight of 3,400 g.
Percentile positions (percentile points) Change in birth weight (grams) Change in POBW (%)
Range Change Range Change Range Change
50th-45th 5 3400-3357 43 100-98.74 1.3
10th-5th 5 2958-2832 126 87.0-83.3 3.7
5th-1st 4 2832-2681 151 83.3-78.9 4.4BMC Pediatrics 2005, 5:13 http://www.biomedcentral.com/1471-2431/5/13
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Failure to utilise the advantages of a ratio may in part be
due to clinical unfamiliarity. In contrast to percentile posi-
tion, there is little literature describing the clinical associ-
ations of appropriateness of growth expressed as
proportions of a desirable birth dimension [21]. For this
reason we have included Table 7 which gives the esti-
mated mean, over gestational weeks 38 – 41 inclusive and
each gender and parity group, proportion of optimal ratio
values of the 3rd, 10th and 90th percentile positions, of each
distribution of weight, length and head circumference at
birth. This table of equivalences enables an approximate
translation of the literature using percentile positions to
percentages of optimal dimensions. The populations
from which percentiles are derived will seldom be con-
fined to those without factors affecting growth pathologi-
cally. The proportion of optimal equivalences in Table 7
will over-estimate the appropriateness of growth of per-
centile defined groups to an extent depending on the bur-
den of growth restricting pathologies in their reference
sample. When POBW becomes familiar, its numerical val-
ues will convey more precise and generalisable clinical
meaning than the traditional percentile positions.
Sample selection
The sample was limited to singleton births to Caucasian
mothers. It is not useful to classify all determinants of
intrauterine growth according to whether or not they have
a pathological effect on growth. For example, twin
pregnancy slows fetal growth particularly in the third
trimester; and gestation-specific perinatal outcomes for
multiple births delivered at term are not as good as those
for singletons [22-24]. However, it is seldom desirable to
reduce twin pregnancies to singleton pregnancies and rea-
sonable to ask whether a twin fetus is growing appropri-
ately, given that it is a twin. Multiplicity-specific fetal
growth standards would be required to answer this
question.
Maternal race is also a problematic factor. The observed
variation in intra-uterine growth rates between ethnic
groups [7,6] may reflect genetically determined differ-
ences in optimal rates and/or systematic differences in
incidence of growth restricting pathologies and/or envi-
ronmental exposures. That is, the association between
growth and maternal race may arise as a result of either or
both non-pathological and pathological determinants of
fetal growth. If racial variation in intrauterine growth
arises purely as a result of pathological determinants,
maternal race is merely associated with growth rate, rather
than being a determinant, and should not be controlled.
The balance between non-pathological and pathological
influences is likely to vary between ethnic groups and
between locations. For example, in Western Australian
(WA) Indigenous communities the tendency to slower
fetal growth relative to Caucasians is believed to be prima-
rily a result of a higher incidence of growth restricting
pathologies and environmental exposures [11]. In south
east Asian communities living in WA women also tend to
have small babies but their perinatal outcomes are similar
to those of WA Caucasians. It is reasonable to differentiate
birth weight distributions by race only if race is itself a
(non-pathological) determinant of fetal growth. Whether
this is the case may be determined by comparing the esti-
mations for optimal fetal growth, adjusted for non-patho-
logical determinants, between populations of different
races, after excluding pregnancies with evidence of expo-
sure to pathological growth determining factors. If the
estimations are significantly and systematically different,
race specific standards are required. If they are not, the
same standards for optimal fetal growth may be used even
if the observed distributions in birth weight differ.
The aim of many of our exclusion criteria was to select a
sample of births that had not been exposed to factors that
have a pathological effect on intrauterine growth.
Although the selection criteria only consider causes of
growth anomaly we anticipated that selected births would
be more likely to be born at term, be larger and born to
taller, older and less disadvantaged mothers for several
reasons. For example, pathologically affected growth is
more often restricted than accelerated and is also associ-
ated with preterm birth and maternal smoking, the most
prevalent pathological determinant of intrauterine
growth, is associated with maternal age and socio-eco-
nomic circumstances. Table 2 shows these anticipations to
be realised. Selected births were also somewhat more
likely to be female, supporting the general observation of
the female advantage during gestation.
We believe that the curves shown in Figure 2 demonstrate
that the exclusion of pathologically affected intrauterine
growth, and of erroneous gestational estimates, has been
reasonably successful. Biological growth (of which fetal
growth is an example) typically proceeds to produce a
Gaussian distribution at any point in time, with the stand-
ard deviation being proportional to the mean. Charts of
unselected birth weights against gestational duration usu-
ally demonstrate increasing dispersion with decreasing
gestation of delivery for deliveries before 40 weeks. There
are two reasons for this: (i) the proportion of erroneously
reported gestational age values increases with decreasing
gestation, simply because the number of births actually
delivered at any gestation week decreases the further it is
from the modal value. Typically, erroneous preterm gesta-
tional reporting underestimates true gestational duration,
hence the birth weight associated with an erroneously
reported preterm gestational age is typically higher than
those of births actually delivered at the reported gestation.BMC Pediatrics 2005, 5:13 http://www.biomedcentral.com/1471-2431/5/13
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(ii) Birth much before term often has a pathological cause
that also influences fetal growth. Thus the distributions of
birth weights delivered at preterm gestations are no longer
Gaussian, but typically, because pathological restriction
occurs much more frequently than acceleration, are
negatively skewed. Thus weights of neonates born at pre-
term gestations tend to be lower than fetuses of the same
gestational age who go on to deliver at term.
In this study we address (i) by using the best estimate of
gestational age that can be derived from all available
data[16] and to exclude the '4-week errors' arising from
gestational break-through bleeding. If we have succeeded
in excluding pregnancies exposed to factors known to
pathologically affect fetal growth we have addressed (ii),
though the cost is the exclusion of a disproportionate
number of infants born preterm, particularly very pre-
term, as can be seen in Table 2. The observation that the
POBWs of the percentile positions are independent of ges-
tational age, Figure 2, indicates that the dispersion is pro-
portional to the mean across gestational age, and is
compatible with both (i) and (ii) having been successfully
addressed.
Selection of independent variables
Some may consider our selection of predictor variables
incomplete as it does not include measures of paternal
size, maternal weight or maternal weight gain.
Paternal size
While paternal size is known to influence fetal growth it
was not included because the biological father cannot
routinely be identified and therefore measures of paternal
size are not available on our database. The proportion of
variability accounted for by the regression equations
would, no doubt, be increased by the inclusion of pater-
nal height as an independent variable.
Maternal weight
It has been suggested that maternal size affects fetal
growth because it correlates with the area of uterine
endometrium available for placentation. Since this area is
not directly measurable, it is logical to seek and adjust for
the maternal dimension(s) that correlates most closely
with it. Maternal height measures skeletal size in the ver-
tical dimension only, while maternal weight is associated
with skeletal size and soft tissue mass, including adipose
tissue. Skeletal height tends to correlate with skeletal size,
but the proportion of weight consisting of soft tissue, par-
ticularly adipose tissue, is very variable, weakening the
correlation between maternal weight and skeletal size.
Data from the 5 month Dutch famine suggest that mater-
nal pre-natal weight for height, a measure of soft tissue
mass, is not a strong determinant of birth weight [25]. We
therefore suggest that maternal height is likely to correlate
better with the uterine area available for placentation than
is prenatal maternal weight or weight for height.
Maternal weight gain
Maternal weight gain is occasionally considered to be a
determinant of birth weight [26]. However fetal weight
can be expected to correlate with maternal weight gain,
because fetal weight, and its correlate placental weight, are
significant components of maternal weight gain. Thus
rather than being a non-pathological determinant of fetal
weight, maternal weight gain partially measures  fetal
growth, whether or not it is optimal and should therefore
not be adjusted for when estimating appropriateness of
growth.
The non-pathological determinants of growth used in
these models accounted for 40.5%, 32.2% and 25.2% of
the variance in birth weight, length and head circumfer-
ence respectively. The variation between these propor-
tions may result from variation in the accuracy with which
each birth dimension can be measured. Birth weight is
routinely measured to within 5 g, representing about
0.15% of a median weight baby. Compared with birth
weight birth, length is more difficult to measure reliably
due to the tendency of the neonate to flex and the facility
with which it may be stretched. Measured head circumfer-
ence at delivery may be influenced by moulding of the
head during passage through the birth canal. The effect of
moulding on head circumference may be largely avoided
by waiting until 2 days after birth before measurement.
However with early discharge policies, such a wait risks
failing to obtain any measurement of head circumference
and in WA head circumference is routinely measured in
the delivery room.
The highly significant, though small, dependence of head
circumference on maternal age, despite adjustment for
parity, was unexpected and requires confirmation in inde-
pendent samples
Inclusion of maternal height and age as linear variables
All three dependent variables were found to have a linear
dependence on maternal height in the range 147–183 cm.
Outside this range there was a tendency for regression to
the mean value of the dimension. This may occur because
we could not include a term for paternal height and there
will be a tendency for women at the extremes of height to
have partners with heights that are less extreme. However
since only 269 (~0.4%) of our selected sample had a
height outside this range, maternal height was included as
a linear variable.
Of the three dependent variables only head circumference
had an association with maternal age, which was found to
be linear up to age 45 years. Only 16 (0.03%) of ourBMC Pediatrics 2005, 5:13 http://www.biomedcentral.com/1471-2431/5/13
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selected sample were older than 45 at the time of delivery,
therefore maternal age was also included as a linear
variable.
Comparisons with previous methods of assessing 
intrauterine growth
In 1963 Lubchenco and colleagues [27] presented the first
percentile charts of gender- and gestation-specific birth
weights for an unselected population of live births and
thereby initiated the modern study of intrauterine growth.
The next major innovation in the methods of assessing
intrauterine growth was the development of customised
computer generated charts for individual neonates [4] by
adding to gender and gestational duration the following
predictor variables: maternal height, weight, ethnic group,
parity and the birth weight, gestational duration and gen-
der of any previous siblings, with the option of further
adding measures of growth taken during the index
pregnancy. The charts were again presented as percentiles.
These charts were designed to predict birth weight rather
than assess appropriateness of growth, as not all the inde-
pendent variables (eg. sibling growth and ethnic group)
are necessarily non-pathological determinants of intrau-
terine growth.
In 1993, Wilcox and colleagues [6] introduced the con-
cept of the birth weight ratio, the ratio of the observed
birth weight to the birth weight predicted given gesta-
tional duration, fetal gender, maternal height, weight,
parity and ethnic group. Their study sample excluded
multiple births, stillbirths and congenitally abnormal
babies, and limited their analysis to term births, but did
not attempt to exclude pregnancies affected by other path-
ological determinants of growth. Poor growth was defined
on the basis of a percentile position of the birth weight
ratio, thereby retaining the problems inherent in the use
of percentile positions as standards.
Summary
The method reported in this paper introduces two innova-
tions, (i) using optimal, rather than expected, growth as
the standard, and (ii) reporting the ratio of the observed
to optimal birth dimension as the indicator of appropri-
ateness of growth, rather than a percentile position.
We sought a sample with optimal opportunities for fetal
growth for the creation of standard both because this is
the logical standard and also to avoid the problem of the
varying incidence of growth restricting pathology and
environmental exposures between populations. Our pre-
viously published birth weight standards for Western Aus-
tralia [17] excluded only perinatal deaths from the
reference sample because other relevant data were not
available at the population level. In subsequent models,
we explored the possibility of using ratios rather than per-
centiles [11,20], the effects of maternal height and parity
were estimated in broad strata and those of maternal age
were not considered. Although births affected by some
factors suggesting supoptimal growth could be excluded,
data concerning the most commonly occurring patholog-
ical growth restricting exposure, maternal smoking, were
not then available at the population level.
The creation of the standards for optimal fetal growth for
Caucasian singletons presented here is possible in part
due to additional methods of estimating gestational dura-
tion [16], the ability to exclude the large proportion of
births to women who smoked or experienced factors
known to affect fetal growth and more complete informa-
tion concerning non-pathological determinants of
growth. Computing and statistical methods have also
been improved with the use of (a) the Box-Cox transfor-
mation to account for any non-normality in the distribu-
tion of the response variables (b) fractional polynomial
regression which required no assumptions regarding the
form of the relationship between gestational duration and
each of the response variables and facilitated the use of
continuous variables thereby allowing the effects of non-
pathological determinants of growth to be estimated
more precisely.
Conclusion
We have presented a comprehensive guide to an alterna-
tive method of creating standards for newborn dimen-
sions and assessing appropriateness of intrauterine
growth. It is based on the estimation of the optimal value
for the dimension which we define as the value obtained
by regression techniques from a large sample of women
without risk factors for intrauterine growth anomaly. In
this method, appropriateness of intrauterine growth is
expressed as the ratio of the observed birth dimension to
the optimal birth dimension rather than as being above or
below a specified percentile position of the population
distribution of that dimension, avoiding the problems
inherent in the use of percentile position. Since POBW is
a measure of appropriateness of intrauterine growth it
may be used as a continuous variable and subjected to
parametric statistical analysis. The use of POBW in clinical
and research settings will prove whether it is a more pre-
cise predictor of compromise within individuals than pre-
viously available indicators of intrauterine growth status.
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